NCPA Political Action Committee (NCPA PAC) News

Transcription

1 OCTOBER 2014 NCPA PAC UPDATE National Community Pharmacists Association Political Action Committee P3. Pharmacy Bills Continue to Gain Support in Congress. P3. NCPA Federal Legislative Priorities P5. Congressional Pharmacy Caucus P5. NCPA PAC Supports a Bi- Partisan Roster of Candidates NCPA Political Action Committee (NCPA PAC) News IT S OCTOBER AND THE HALLS OF CONGRESS ARE EMPTY! One-third of the Senate and every member of the House of Representatives are at home pounding the campaign trail as they prepare for the upcoming election. Midterm elections are often regarded as a referendum on the sitting President s and/or incumbent party s performance. They usually don t turn out well for the party of the President; over the past 21 midterm elections, the President s party has lost an average of 29 seats in the House and an average of 6 seats in the Senate. Post-World War II Midterm Elections Following Presidential Reelection Year President Party In-Party Seat Change: House In-Party Seat Change: Senate 1958 Eisenhower Republican Kennedy/ Johnson Democrat Nixon/Ford Republican Reagan Republican Clinton Democrat G.W. Bush Republican AVG Thank you to all of our NCPA PAC supporters this election cycle. As a distinguished PAC member, you should hold your head high. Without your support, independent community pharmacy would have gone unnoticed. Source: Vital Statistics on Congress 100 Daingerfield Road Alexandria, VA

2 Senate Races Update Source: The Cook Political Report Current Senate Lineup: 53 Democrats, 45 Republicans, 2 Independents (32 seats up in 2014) Democrats are at a disadvantage of having to defend 21 seats with Republicans defending 15. Republicans would need a net gain of six seats to take the majority and are on track to pick up between four and seven seats, meaning it will be a slim majority for either party. House Races Update Source: The Cook Political Report Current House Lineup: 233 Republicans, 199 Democrats, 3 Vacancies Republicans hold the majority in the House with 233 seats. For Democrats to take control of the House they would need to secure 17 seats. Large shifts or a change in partisan control of the House are unlikely due to President Obama s low approval ratings and the GOP s midterm turnout advantages. Republicans appear on track to expand their House majority by between two and 12 seats.

3 Pharmacy Bills Continue to Gain Support in Congress NCPA has continued to educate members of Congress and their staffs about NCPA s legislative priorities and bills. A list of members that signed-on to each of our bills is below. These members of Congress support Community Pharmacy; please continue to support these members of Congress. NCPA Federal Legislative Priorities H.R Preferred Network Fairness Legislation On May 6th legislation was introduced by Representatives Morgan Griffith (VA) and Peter Welch (VT) that would allow independent pharmacies to participate in preferred networks if: one or more of their stores are located in a health professional shortage area; one or more of their stores are located in a medically underserved population; and if they can meet terms and conditions that are comparable to other in-network pharmacies. Lead Sponsors: Reps. Griffith, H. Morgan [VA-9] and Welch, Peter [VT-AL] Rep. Barletta, Lou [PA-11] Rep. Beatty, Joyce [OH-3] Rep. Bishop, Sanford D., Jr. [GA-2] Rep. Bishop, Timothy H. [NY-1] Rep. Braley, Bruce L. [IA-1] Rep. Bustos, Cheri [IL-17] Rep. Capito, Shelley Moore [WV-2] Rep. Cartwright, Matt [PA-17] Rep. Clarke, Yvette D. [NY-9] Rep. Cole, Tom [OK-4] Rep. Collins, Chris [NY-27] Rep. Collins, Doug [GA-9] Rep. Cotton, Tom [AR-4] Rep. Courtney, Joe [CT-2] Rep. Crawford, Eric A. Rick [AR-1] Rep. Davis, Rodney [IL-13] Rep. DeFazio, Peter A. [OR-4] Rep. Deutch, Theodore E. [FL-21] Rep. Doggett, Lloyd [TX-35] Rep. Duncan, John J., Jr. [TN-2] Rep. Ellmers, Renee L. [NC-2] Rep. Fleischmann, Charles J. Chuck [TN-3] Rep. Forbes, J. Randy [VA-4] Rep. Fortenberry, Jeff [NE-1] Rep. Gallego, Pete P. [TX-23] Rep. Goodlatte, Bob [VA-6] Rep. Guthrie, Brett [KY-2] Rep. Harper, Gregg [MS-3] Rep. Hinojosa, Ruben [TX-15] Rep. Jones, Walter B., Jr. [NC-3] Rep. Kelly, Mike [PA-3] Rep. Kildee, Daniel T [MI-5] Rep. Lipinski, Daniel [IL-3] Rep. Loebsack, David [IA-2] Rep. Lujan Grisham, Michelle [NM-1] Rep. Massie, Thomas [KY-4] Rep. McAllister, Vance M. [LA-5] Rep. McIntyre, Mike [NC-7] Rep. McKinley, David B. [WV-1] Rep. Noem, Kristi L. [SD] Rep. Nunnelee, Alan [MS-1] Rep. Olson, Pete [TX-22] Rep. Owens, William L. [NY-21] Rep. Peterson, Collin C. [MN-7] Rep. Rahall, Nick J., II [WV-3] Rep. Reed, Tom [NY-23] Rep. Ribble, Reid J. [WI-8] Rep. Rice, Tom [SC-7] Rep. Roe, David P. [TN-1] Rep. Rogers, Mike D. [AL-3] Rep. Ruppersberger, C. A. Dutch [MD-2] Rep. Rush, Bobby L. [IL-1] Rep. Ryan, Tim [OH-13] Rep. Sarbanes, John P. [MD-3] Rep. Scott, Austin [GA-8] Rep. Scott, David [GA-13] Rep. Shuster, Bill [PA-9] Rep. Slaughter, Louise McIntosh [NY-25] Rep. Smith, Lamar [TX-21] Rep. Southerland, Steve II [FL-2] Rep. Thompson, Bennie G. [MS-2] Rep. Tierney, John F. [MA-6] Rep. Tonko, Paul [NY-20] Rep. Walz, Timothy J. [MN-1] Rep. Westmoreland, Lynn A. [GA-3] Rep. Whitfield, Ed [KY-1] Rep. Wilson, Joe [SC-2] H.R Generic Drug Pricing Transparency Bill On April 9th legislation was introduced by Representatives Doug Collins (GA) and Dave Loebsack (IA) that would provide transparency and fairness to community pharmacies regarding their reimbursements for generic drugs. This measure would require pharmacy benefit managers (PBMs) to disclose the rate of reimbursement in the contract and to update that rate at least once every seven days to reflect fluctuations in the market. Lead Sponsors: Reps. Collins, Doug [GA-9] and Loebsack, Dave [IA-2] Rep. Barletta, Lou [PA-11] Rep. Barton, Joe [TX-6] Rep. Bishop, Sanford D., Jr. [GA-2] Rep. Coffman, Mike [CO-6] Rep. Crawford, Eric A. Rick [AR-1] Rep. Duncan, John J., Jr. [TN-2] Rep. Fattah, Chaka [PA-2] Rep. Fortenberry, Jeff [NE-1] Rep. Scott, Austin [GA-8] Rep. Southerland, Steve II [FL-2] Rep. Williams, Roger [TX-25] Rep. Young, Don [AK] S. 867 PBM Audit and Generic Drug Pricing Transparency Legislation This bill addresses the lack of generic pricing transparency on the part of PBMs in the Medicare Part D program and promotes fairness by curbing abusive PBM audit practices. It would ban extrapolation, prohibit recoupments based on minor typographical errors that have

4 no financial harm to patient or plan, and assure recoveries made in cases of fraud, waste, and abuse be returned to taxpayers and beneficiaries, not retained by PBM middlemen. Lead Sponsor: Sen. Blumenthal, Richard [CT] Sen. Casey, Robert P., Jr. [PA] Sen. Gillibrand, Kirsten E. [NY] Sen. Murphy, Christopher S. [CT] H.R Provider Status Bill This bill would recognize pharmacists as providers under the Medicare Part B program. If enacted, pharmacists would be able to perform services for patients consistent with the state scope of practice law in which they practice for patients that reside in medically underserved areas. Lead Sponsors: Reps. Guthrie, Brett [KY-2], Young, Todd (IN-9] and Butterfield, G.K. [NC-1] Rep. Barletta, Lou [PA-11] Rep. Barr, Andy [KY-6] Rep. Bass, Karen [CA-37] Rep. Beatty, Joyce [OH-3] Rep. Bentivolio, Kerry L. [MI-11] Rep. Bera, Ami [CA-7] Rep. Bishop, Timothy H. [NY-1] Rep. Braley, Bruce L. [IA-1] Rep. Brooks, Susan W. [IN-5] Rep. Bustos, Cheri [IL-17] Rep. Capito, Shelley Moore [WV-2] Rep. Carson, Andre [IN-7] Rep. Clay, Wm. Lacy [MO-1] Rep. Coffman, Mike [CO-6] Rep. Cohen, Steve [TN-9] Rep. Collins, Doug [GA-9] Rep. Courtney, Joe [CT-2] Rep. Cuellar, Henry [TX-28] Rep. Davis, Danny K. [IL-7] Rep. Davis, Rodney [IL-13] Rep. DeFazio, Peter A. [OR-4] Rep. Dent, Charles W. [PA-15] Rep. Duckworth, Tammy [IL-8] Rep. Duncan, John J., Jr. [TN-2] Rep. Ellison, Keith [MN-5] Rep. Ellmers, Renee L. [NC-2] Rep. Enyart, William L. [IL-12] Rep. Forbes, J. Randy [VA-4] Rep. Fudge, Marcia L. [OH-11] Rep. Garcia, Joe [FL-26] Rep. Graves, Sam [MO-6] Rep. Griffin, Tim [AR-2] Rep. Griffith, H. Morgan [VA-9] Rep. Hall, Ralph M. [TX-4] Rep. Harper, Gregg [MS-3] Rep. Holt, Rush [NJ-12] Rep. Honda, Michael M. [CA-17] Rep. Hunter, Duncan D. [CA-50] Rep. Jackson Lee, Sheila [TX-18] Rep. Jeffries, Hakeem S. [NY-8] Rep. Jenkins, Lynn [KS-2] Rep. Johnson, Bill [OH-6] Rep. Johnson, Henry C. Hank, Jr. [GA-4] Rep. Jolly, David [FL-13] Rep. Joyce, David P. [OH-14] Rep. Kelly, Robin L. [IL-2] Rep. Kinzinger, Adam [IL-16] Rep. Kirkpatrick, Ann [AZ-1] Rep. Langevin, James R. [RI-2] Rep. Lipinski, Daniel [IL-3] Rep. Loebsack, David [IA-2] Rep. Long, Billy [MO-7] Rep. Luetkemeyer, Blaine [MO-3] Rep. Lujan Grisham, Michelle [NM-1] Rep. Lujan, Ben Ray [NM-3] Rep. Massie, Thomas [KY-4] Rep. Matsui, Doris O. [CA-6] Rep. McAllister, Vance M. [LA-5] Rep. McGovern, James P. [MA-2] Rep. Meadows, Mark [NC-11] Rep. Miller, Candice S. [MI-10] Rep. Moore, Gwen [WI-4] Rep. Murphy, Patrick [FL-18] Rep. Napolitano, Grace F. [CA-32] Rep. Noem, Kristi L. [SD] Rep. Nolan, Richard M. [MN-8] Rep. Nunes, Devin [CA-22] Rep. Olson, Pete [TX-22] Rep. Owens, William L. [NY-21] Rep. Paulsen, Erik [MN-3] Rep. Pearce, Stevan [NM-2] Rep. Perry, Scott [PA-4] Rep. Peterson, Collin C. [MN-7] Rep. Pierluisi, Pedro R. [PR] Rep. Pocan, Mark [WI-2] Rep. Poe, Ted [TX-2] Rep. Rahall, Nick J., II [WV-3] Rep. Reed, Tom [NY-23] Rep. Roe, David P. [TN-1] Rep. Rogers, Mike J. [MI-8] Rep. Rooney, Thomas J. [FL-17] Rep. Ross, Dennis A. [FL-15] Rep. Rush, Bobby L. [IL-1] Rep. Ryan, Tim [OH-13] Rep. Schakowsky, Janice D. [IL-9] Rep. Schiff, Adam B. [CA-28] Rep. Schneider, Bradley S. [IL-10] Rep. Schock, Aaron [IL-18] Rep. Scott, David [GA-13] Rep. Shuster, Bill [PA-9] Rep. Southerland, Steve II [FL-2] Rep. Stewart, Chris [UT-2] Rep. Takano, Mark [CA-41] Rep. Terry, Lee [NE-2] Rep. Thompson, Bennie G. [MS-2] Rep. Thompson, Mike [CA-5] Rep. Thornberry, Mac [TX-13] Rep. Walz, Timothy J. [MN-1] Rep. Welch, Peter [VT] Rep. Whitfield, Ed [KY-1] Rep. Wilson, Frederica S. [FL-24] Rep. Wilson, Joe [SC-2] Rep. Young, Don [AK] H.R Improving Communication between DEA and Pharmacies Regarding Controlled Substances. The bill would allow pharmacies the opportunity to submit a corrective action plan prior to having their DEA license revoked or suspended. It also seeks to create a more collaborative partnership between drug manufacturers, wholesalers, retail pharmacies, and federal enforcement and oversight agencies.

5 Lead Sponsor: Rep. Hastings, Alcee L. [FL-20] Rep. Bishop, Sanford D., Jr. [GA-2] Rep. Cartwright, Matt [PA-17] Rep. Conyers, John, Jr. [MI-13] Rep. Denham, Jeff [CA-10] Rep. Fortenberry, Jeff [NE-1] Rep. Kaptur, Marcy [OH-9] Rep. Michaud, Michael H. [ME-2] Rep. Petri, Thomas E. [WI-6] Rep. Pingree, Chellie [ME-1] Rep. Shea-Porter, Carol [NH-1] Rep. Speier, Jackie [CA-14] Rep. Welch, Peter [VT] Congressional Pharmacy Caucus The Congressional Pharmacy Caucus is chaired by Representatives Austin Scott (GA) and Peter Welch (VT). The Caucus efforts extend beyond pushing for passage of legislation to include educating their colleagues and the public about value of community pharmacies to our health care system. NCPA thanks the following members for serving on the Caucus this year. House Community Pharmacy Caucus Co-Chairs Reps. Scott, Austin [GA-8] and Welch, Peter [VT-At Large] Rep. Robert Aderholt [AL-4] Rep. Lou Barletta [PA-11] Rep. John Barrow [GA-12] Rep. Cheri Bustos [IL-17] Rep. Joe Courtney [CT-2] Rep. Collin Peterson [MN-7] Rep. Peter DeFazio [OR-4] Rep. Lloyd Doggett [TX-35] Rep. Jeff Fortenberry [NE-1] Rep. Virginia Foxx [VA-5] Rep. Jim Gerlach [PA-6] Rep. Bob Goodlatte [VA-6] Rep. Tim Griffin [AR-2] Rep. Morgan Griffith [VA-9] Rep. Jamie Herrera [WA-3] Rep. Eddie Bernice Johnson [TX-30] Rep. Walter Jones [NC-3] Rep. David Joyce [OH-14] Rep. Steve Kind [IA-4] Rep. Frank LoBiondo [NJ-2] Rep. Dave Loebsack [IA-2] Rep. Carolyn McCarthy [NY-4] Rep. Mike McIntyre [NC-7] Rep. Bill Posey [FL-8] Rep. David Price [NC-4] Rep. Rick Larsen [WA-2] Rep. Mike Rogers [MI-8] Rep. Linda Sanchez [CA-38] Rep. Sean Maloney [NY-18] Rep. Peter Sessions [TX-32] Rep. Louise Slaughter [NY-25] Rep. Greg Walden [OR-2] Rep. Lynn Westmoreland [GA-3] Rep. Roger Williams [TX-25] NCPA PAC Supports a Bipartisan Roster of Candidates The NCPA PAC is proud to have supported the following candidates who have demonstrated their commitment to our profession, our businesses, and our patients. These candidates understand the importance of community pharmacy and together they form the foundation of a Community Pharmacy Majority necessary for legislative success in Congress. We are encouraging pharmacists, their employees, and patients to support these candidates on or before November 4th, and to get involved in their campaigns. Sen. Lamar Alexander (R) TN Rep. Mark E. Amodei (R) NV 2 Rep. John Jenkins Barrow (D) GA 12 Rep. Karen R. Bass (D) CA 37 Rep. Joyce Beatty (D) OH 3 Rep. Xavier Becerra (D) CA 34 Aimee R. Belgard (D) NJ 3 Rep. Sanford D. Bishop, Jr. (D) GA 2 Rep. Timothy H. Bishop (D) NY 1 Rep. Marsha Blackburn (R) TN 7 Rodney Leland Blum (R) IA 1 Rep. Earl Blumenauer (D) OR 3 Rep. John A. Boehner (R) OH 8 Rep. Charles W. Boustany, Jr. (R) LA 3 Brendan F. Boyle (D) PA 13 Rep. Kevin Brady (R) TX 8 Rep. Bruce L. Braley (D) IA Rep. Susan W. Brooks (R) IN 5 Rep. Michael Clifton Burgess (R) TX 26 Rep. Cheryl L. Bustos (D) IL 17 Rep. G. K. Butterfield (D) NC 1 Rep. Bradley Byrne (R) AL 1

6 Rep. Shelley Moore Capito (R) WV Rep. Lois Capps (D) CA 24 Buddy Carter (R) GA 1 Rep. Matthew A. Cartwright (D) PA 17 Rep. William Cassidy (R) LA Rep. Katherine Anne Castor (D) FL 14 Rep. Judy Chu (D) CA 27 Rep. James E. Clyburn (D) SC 6 Sen. William Thad Cochran (R) MS Rep. Mike Coffman (R) CO 6 Rep. Thomas Jeffery Cole (R) OK 4 Rep. Christopher Carl Collins (R) NY 27 Rep. Douglas Allen Collins (R) GA 9 Sen. Susan Margaret Collins (R) ME Barbara J. Comstock (R) VA 10 Rep. Gerald E. Connolly (D) VA 11 Rep. John Conyers, Jr. (D) MI 13 Sen. John Cornyn, III (R) TX Ryan A. Costello (R) PA 6 Rep. Joseph D. Courtney (D) CT 2 Rep. Kevin J. Cramer (R) ND 1 Rep. Joseph Crowley (D) NY 14 Rep. Henry Roberto Cuellar (D) TX 28 Rep. Steve Daines (R) MT Rep. Rodney L. Davis (R) IL 13 Rep. Diana L. DeGette (D) CO 1 Rep. Suzan Kay DelBene (D) WA 1 Rep. Jeffrey Denham (R) CA 10 Rep. Charles W. Dent (R) PA 15 Rep. Lloyd Doggett (D) TX 35 Rep. Michael F. Doyle (D) PA 14 Sen. Richard J. Durbin (D) IL Rep. Renee Jacisin Ellmers (R) NC 2 Sen. Michael B. Enzi (R) WY Rep. Charles J. Fleischmann (R) TN 3 Rep. Jeff Fortenberry (R) NE 1 Sen. Al Franken (D) MN Rep. Marcia L. Fudge (D) OH 11 Rep. Pete P. Gallego (D) TX 23 Ruben Gallego (D) AZ 7 Rep. Cory Gardner (R) CO Rep. Christopher Patrick Gibson (R) NY 19 Rep. Robert William Goodlatte (R) VA 6 Sen. Lindsey O. Graham (R) SC Rep. Samuel B. Graves, Jr. (R) MO 6 Rep. Raymond Eugene Green (D) TX 29 Rep. H. Morgan Griffith (R) VA 9 Rep. Michelle Lujan Grisham (D) NM 1 Rep. S. Brett Guthrie (R) KY 2 Sen. Kay R. Hagan (D) NC Rep. Gregory Harper (R) MS 3 Rep. Jaime Herrera Beutler (R) WA 3 J. French Hill (R) AR 2 Rep. James A. Himes (D) CT 4 Rep. Ruben E. Hinojosa (D) TX 15 Rep. Michael M. Honda (D) CA 17 Rep. Steny H. Hoyer (D) MD 5 Rep. Richard Lane Hudson, Jr. (R) NC 8 Sen. James Mountain Inhofe (R) OK Rep. Steve J. Israel (D) NY 3 Rep. Lynn Jenkins (R) KS 2 Rep. Bill Johnson (R) OH 6 Rep. Henry C. Johnson, Jr. (D) GA 4 Rep. Walter B. Jones (R) NC 3 Rep. David P. Joyce (R) OH 14 Rep. Joseph P. Kennedy (D) MA 4 Rep. Daniel Timothy Kildee (D) MI 5 Rep. Ron Kind (D) WI 3 Terri Lynn Land (R) MI Rep. Robert E. Latta (R) OH 5 Rep. Sander M. Levin (D) MI 9 Ted W. Lieu (D) CA 33 Rep. Daniel William Lipinski (D) IL 3 Rep. David Loebsack (D) IA 2 Mia Love (R) UT 4 Rep. Daniel Benjamin Maffei (D) NY 24 Rep. Sean Patrick Maloney (D) NY 18 Rep. Thomas Anthony Marino (R) PA 10 Rep. Kevin McCarthy (R) CA 23 Sen. Mitch McConnell (R) KY

7 Rep. Jim McDermott (D) WA 7 Rep. David B. McKinley (R) WV 1 Rep. Cathy McMorris Rodgers (R) WA 5 Martha McSally (R) AZ 2 Rep. Patrick L. Meehan (R) PA 7 Rep. Patrick E. Murphy (D) FL 18 Rep. Richard Edmund Neal (D) MA 1 Daniel Newhouse (R) WA 4 Rep. Kristi Lynn Noem (R) SD 1 Donald W. Norcross (D) NJ 1 Rep. Richard B. Nugent (R) FL 11 Rep. Devin G. Nunes (R) CA 22 Rep. Patrick Alan Nunnelee (R) MS 1 Rep. Peter Graham Olson (R) TX 22 Rep. Frank Pallone, Jr. (D) NJ 6 David A. Perdue (R) GA Rep. Edwin G. Perlmutter (D) CO 7 Rep. Scott Gordon Perry (R) PA 4 Rep. Collin C. Peterson (D) MN 7 Rep. Joseph R. Pitts (R) PA 16 Rep. Michael Richard Pompeo (R) KS 4 Sen. Mark Lunsford Pryor (D) AR Rep. Thomas W. Reed, II. (R) NY 23 Rep. David G. Reichert (R) WA 8 Rep. James B. Renacci (R) OH 16 Rep. Reid Ribble (R) WI 8 Rep. E. Scott Rigell (R) VA 2 Sen. James E. Risch (R) ID Sen. Pat Roberts (R) KS Rep. Martha Roby (R) AL 2 Rep. Michael Dennis Rogers (R) AL 3 Rep. Peter J. Roskam (R) IL 6 M. Michael Rounds (R) SD Rep. C.A. Dutch Ruppersberger (D) MD 2 Rep. Paul Ryan (R) WI 1 Benjamin E. Sasse (R) NE Rep. Stephen J. Scalise (R) LA 1 Rep. Janice D. Schakowsky (D) IL 9 Sen. Brian Emanuel Schatz (D) HI Rep. Adam B. Schiff (D) CA 28 Rep. Aaron Schock (R) IL 18 Rep. James Austin Scott (R) GA 8 Sen. Timothy Eugene Scott (R) SC Rep. Peter Anderson Sessions (R) TX 32 Rep. Terri A. Sewell (D) AL 7 Rep. John M. Shimkus (R) IL 15 Rep. William F. Shuster (R) PA 9 Rep. Louise McIntosh Slaughter (D) NY 25 Rep. Lamar Seeligson Smith (R) TX 21 Rep. Adrian M. Smith (R) NE 3 Rep. Jason T. Smith (R) MO 8 Rep. William Steve Southerland, II (R) FL 2 Elise M. Stefanik (R) NY 21 Rep. Christopher Douglas Stewart (R) UT 2 Rep. Steve Stivers (R) OH 15 Anthony A. Strickland (R) CA 25 Rep. Lee Terry (R) NE 2 Rep. Michael C. Thompson (D) CA 5 Rep. Patrick J. Tiberi (R) OH 12 Rep. Paul D. Tonko (D) NY 20 David A. Trott (R) MI 11 Rep. Fredrick Stephen Upton (R) MI 6 Rep. David G. Valadao (R) CA 21 Rep. Ann L. Wagner (R) MO 2 Rep. Greg Walden (R) OR 2 Mimi Walters (R) CA 45 Rep. Timothy J. Walz (D) MN 1 Rep. Peter F. Welch (D) VT 1 Rep. Lynn A. Westmoreland (R) GA 3 Rep. Edward Whitfield (R) KY 1 Rep. Addison Graves Wilson (R) SC 2 James Lee Witt (D) AR 4 Rep. Robert J. Wittman (R) VA 1 Rep. Todd Christopher Young (R) IN 9

8 CONTINUED SUPPORT OF NCPA PAC RAISES THE PROFILE OF INDEPENDENT COMMUNITY PHARMACY! To learn more about NCPA PAC, please contact Karry LaViolette at or Are you willing to give a $1 a day [to the NCPA PAC] to protect your business and your bottom line? Steve Giroux, PAC Chairman, Middleport Family Health Center, Middleport, NY Enrollment Form Yes! I want to protect my pharmacy by helping elect members of Congress who support community pharmacy! Fold and return this form with your contribution to: NCPA PAC, 100 Daingerfield Rd., Alexandria VA For more information, contact: Karry LaViolette, Political Development Director at , fax, or karry.laviolette@ncpanet.org. NAME NCPA MEMBER # COMPANY NAME OCCUPATION HOME ADDRESS CITY/STATE/ZIP PHONE FAX Enclosed is my personal check for a one-time donation, payable to NCPA PAC : m $5,000 m $2,500 m $1,000 m $500 m $365 (Dollar A Day) m Other $ (Partnership and sole proprietorship checks are permitted to PACs; however, corporate funds are prohibited by Federal law.) Please bill my personal credit card: m Visa m MasterCard m American Express m Discover CARD # EXP. DATE NAME ON CARD TODAY S DATE SIGNATURE With monthly contributions of: m $ (maximum allowed) m $250 m $100 m $75 m $50 m Other $ Or, with a one-time contribution of: m $5,000 (maximum allowed) m $2,500 m $1,000 m $500 m $365 m Other $ Contributions to the NCPA PAC are not deductible for federal income tax purposes. Contributions to NCPA PAC are used for political purposes. All contributions are voluntary. You may refuse to contribute without reprisal. The guidelines are merely suggestions; you may chose to contribute more or less than the guidelines suggest, and NCPA will not favor or disadvantage you by reason of the amount of your contribution or your decision not to contribute. Only U.S. citizens (or those who have been lawfully admitted to permanent U.S. residence) are allowed to contribute to NCPA PAC. Federal law requires us to use our best efforts to collect and report the name, mailing address, occupation and name of employer for each individual whose contributions aggregate in excess of $200 in a calendar year. NCPAPAC-2014